Vycor Medical (VYCO) Depreciation & Amortization (CF) (2010 - 2026)
Vycor Medical (VYCO) posted quarterly Depreciation & Amortization (CF) of $15668.0 for Q1 2026, down 2.74% year-over-year from $16110.0 in Q1 2025, and down 2.95% quarter-over-quarter from $16144.0 in Q4 2025.
Vycor Medical (VYCO) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $15668.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 2.74% year-over-year to $15668.0; the TTM figure through Mar 2026 stood at $62701.0 (down 2.64% YoY), while the FY2025 annual figure was $63143.0, down 1.2% from the prior year.
- Depreciation & Amortization (CF) slipped to $15668.0 in Q1 2026 per VYCO's latest filing, from $16144.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $16869.0 in Q4 2024 and bottomed at $15021.0 in Q2 2025.
- Historically, Depreciation & Amortization (CF) has averaged $15580.9 across 5 years, with a median of $15563.0 in 2022.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 39.43% — and 2025, when it declined 4.3%.
- Vycor Medical's Depreciation & Amortization (CF) stood at $15330.0 in 2022, then dropped by 1.49% to $15102.0 in 2023, then grew by 11.7% to $16869.0 in 2024, then declined by 4.3% to $16144.0 in 2025, then decreased by 2.95% to $15668.0 in 2026.
- Business Quant data shows VYCO's Depreciation & Amortization (CF) at $15668.0 in Q1 2026, $16144.0 in Q4 2025, and $15868.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,668.00 |
| Mar 31, 2026 | 15,668.00 |
| Dec 31, 2025 | 16,144.00 |
| Dec 31, 2025 | 16,144.00 |
| Sep 30, 2025 | 15,868.00 |
| Sep 30, 2025 | 15,868.00 |
| Jun 30, 2025 | 15,021.00 |
| Jun 30, 2025 | 15,021.00 |
| Mar 31, 2025 | 16,110.00 |
| Mar 31, 2025 | 16,110.00 |
| Dec 31, 2024 | 16,869.00 |
| Dec 31, 2024 | 16,869.00 |
| Sep 30, 2024 | 15,740.00 |
| Sep 30, 2024 | 15,740.00 |
| Jun 30, 2024 | 15,681.00 |
| Jun 30, 2024 | 15,681.00 |
| Mar 31, 2024 | 15,620.00 |
| Mar 31, 2024 | 15,620.00 |
| Dec 31, 2023 | 15,102.00 |
| Dec 31, 2023 | 15,102.00 |